Want to see MMED full AI Analyst Report?

MiniMed Group, Inc. (MMED) Stock Forecast & Price Target

53 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

MMED Analyst Ratings

Strong Buy

11 Buy

1 Hold

0 Sell

Based on 12 analysts giving stock ratings to

MiniMed

Group, Inc.

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

MMED Stock 12 Month Forecast

Average Price Target

$21.60

▲(10.20% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for MiniMed Group, Inc. in the last 3 months. The average price target is $21.60 with a high forecast of $26.00 and a low forecast of $16.00. The average price target represents a 10.20% change from the last price of $19.60.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"11":"$11","15":"$15","19":"$19","23":"$23","27":"$27"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":26,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$26.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":21.6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$21.60</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$16.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[11,15,19,23,27],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,18.05,18.661538461538463,19.273076923076925,19.884615384615387,20.496153846153845,21.107692307692307,21.71923076923077,22.33076923076923,22.942307692307693,23.553846153846152,24.165384615384617,24.776923076923076,25.388461538461538,{"y":26,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,18.05,18.323076923076925,18.596153846153847,18.86923076923077,19.142307692307693,19.415384615384617,19.68846153846154,19.961538461538463,20.234615384615385,20.50769230769231,20.78076923076923,21.053846153846155,21.326923076923077,{"y":21.6,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,18.05,17.892307692307693,17.734615384615385,17.576923076923077,17.41923076923077,17.26153846153846,17.103846153846153,16.946153846153848,16.78846153846154,16.630769230769232,16.473076923076924,16.315384615384616,16.157692307692308,{"y":16,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":18.49,"date":1754006400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.48,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.11,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.19,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.05,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$26.00

Average Price Target$21.60

Lowest Price Target$16.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Patrick Wood

UBS

$25

Buy

27.55%

Upside

Initiated

07/28/26

MiniMed initiated with a Buy at UBSMiniMed initiated with a Buy at UBS

Joanne Wuensch

Citi

―

Buy

―

Reiterated

07/17/26

Citi Sticks to Its Buy Rating for MiniMed Group, Inc. (MMED)

Travis Steed

Bank of America Securities

$20

Buy

2.04%

Upside

Reiterated

07/15/26

Analyst Reiterates Buy on MMED, Citing Strong Diabetes Tech Pipeline and Execution, With Price Target Unchanged at $20

Marie Thibault

BTIG

$25

Buy

27.55%

Upside

Reiterated

07/09/26

Wall Street Analysts Are Bullish on Top NA Picks

Steven Lichtman

William Blair

―

Buy

―

Reiterated

06/17/26

MiniMed Earns Buy Rating on Flex Launch, CGM Expansion, and Robust Pipeline Driving Accelerated Growth

Larry Biegelsen

Wells Fargo

$22→$26

Buy

32.65%

Upside

Reiterated

06/08/26

Wells Fargo Reaffirms Their Buy Rating on MiniMed Group, Inc. (MMED)

Daniel Markowitz CFA

Evercore ISI

$20

Buy

2.04%

Upside

Reiterated

06/05/26

Evercore ISI Remains a Buy on MiniMed Group, Inc. (MMED)

Kallum Titchmarsh

Morgan Stanley

$14.06→$19

Buy

-3.06%

Downside

Reiterated

06/05/26

Analysts Are Bullish on These NA Stocks: MiniMed Group, Inc. (MMED), Avalyn Pharma Inc (AVLN)

Matthew O'Brien

Piper Sandler

$16

Hold

-18.37%

Downside

Reiterated

06/04/26

Piper Sandler Reaffirms Their Hold Rating on MiniMed Group, Inc. (MMED)

Anthony Petrone

Mizuho Securities

$21

Buy

7.14%

Upside

Reiterated

06/03/26

Analysts Offer Insights on NA Companies: MiniMed Group, Inc. (NASDAQ: MMED) and Janus Living, Inc. Class A (NYSE: JAN)

David Roman

Goldman Sachs

$14.01→$24

Buy

22.45%

Upside

Reiterated

06/03/26

David Roman Lifts MiniMed Price Target to $24, Citing Strong Growth, Margin Outperformance and Compelling Valuation

Bruce Jackson

Benchmark Co.

$20

Buy

2.04%

Upside

Reiterated

06/03/26

Benchmark Co. Reaffirms Their Buy Rating on MiniMed Group, Inc. (MMED)

Pito Chickering

Deutsche Bank

$20

Buy

2.04%

Upside

Initiated

03/31/26

MiniMed initiated with a Buy at Deutsche BankMiniMed initiated with a Buy at Deutsche Bank

Matt Miksic

Barclays

$26

Buy

32.65%

Upside

Initiated

03/31/26

MiniMed initiated with an Overweight at BarclaysMiniMed initiated with an Overweight at Barclays

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Patrick Wood

UBS

$25

Buy

27.55%

Upside

Initiated

07/28/26

MiniMed initiated with a Buy at UBSMiniMed initiated with a Buy at UBS

Joanne Wuensch

Citi

―

Buy

―

Reiterated

07/17/26

Citi Sticks to Its Buy Rating for MiniMed Group, Inc. (MMED)

Travis Steed

Bank of America Securities

$20

Buy

2.04%

Upside

Reiterated

07/15/26

Analyst Reiterates Buy on MMED, Citing Strong Diabetes Tech Pipeline and Execution, With Price Target Unchanged at $20

Marie Thibault

BTIG

$25

Buy

27.55%

Upside

Reiterated

07/09/26

Wall Street Analysts Are Bullish on Top NA Picks

Steven Lichtman

William Blair

―

Buy

―

Reiterated

06/17/26

MiniMed Earns Buy Rating on Flex Launch, CGM Expansion, and Robust Pipeline Driving Accelerated Growth

Larry Biegelsen

Wells Fargo

$22→$26

Buy

32.65%

Upside

Reiterated

06/08/26

Wells Fargo Reaffirms Their Buy Rating on MiniMed Group, Inc. (MMED)

Daniel Markowitz CFA

Evercore ISI

$20

Buy

2.04%

Upside

Reiterated

06/05/26

Evercore ISI Remains a Buy on MiniMed Group, Inc. (MMED)

Kallum Titchmarsh

Morgan Stanley

$14.06→$19

Buy

-3.06%

Downside

Reiterated

06/05/26

Analysts Are Bullish on These NA Stocks: MiniMed Group, Inc. (MMED), Avalyn Pharma Inc (AVLN)

Matthew O'Brien

Piper Sandler

$16

Hold

-18.37%

Downside

Reiterated

06/04/26

Piper Sandler Reaffirms Their Hold Rating on MiniMed Group, Inc. (MMED)

Anthony Petrone

Mizuho Securities

$21

Buy

7.14%

Upside

Reiterated

06/03/26

Analysts Offer Insights on NA Companies: MiniMed Group, Inc. (NASDAQ: MMED) and Janus Living, Inc. Class A (NYSE: JAN)

David Roman

Goldman Sachs

$14.01→$24

Buy

22.45%

Upside

Reiterated

06/03/26

David Roman Lifts MiniMed Price Target to $24, Citing Strong Growth, Margin Outperformance and Compelling Valuation

Bruce Jackson

Benchmark Co.

$20

Buy

2.04%

Upside

Reiterated

06/03/26

Benchmark Co. Reaffirms Their Buy Rating on MiniMed Group, Inc. (MMED)

Pito Chickering

Deutsche Bank

$20

Buy

2.04%

Upside

Initiated

03/31/26

MiniMed initiated with a Buy at Deutsche BankMiniMed initiated with a Buy at Deutsche Bank

Matt Miksic

Barclays

$26

Buy

32.65%

Upside

Initiated

03/31/26

MiniMed initiated with an Overweight at BarclaysMiniMed initiated with an Overweight at Barclays

Stocks with the Highest Top Analyst Consensus in the General Sector

SKHYSK Hynix

ITGITG Inc. Class A

LIMENeutron Holdings, Inc.

EROCERock

CBRSCerebras Systems, Inc. Class A

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering MiniMed Group, Inc.

3 Months

Travis SteedBank of America Securities

Success Rate

4/4 ratings generated profit

Average Return

+36.70%

Copying Travis Steed's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +36.70% per trade.

1 Year

Daniel Markowitz CFAEvercore ISI

Success Rate

3/3 ratings generated profit

Average Return

+45.07%

Copying Daniel Markowitz CFA's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +45.07% per trade.

2 Years

Daniel Markowitz CFAEvercore ISI

Success Rate

3/3 ratings generated profit

Average Return

+45.07%

Copying Daniel Markowitz CFA's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +45.07% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MMED Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, MMED has received 18 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. MMED average Analyst price target in the past 3 months is 21.60.

Each month's total comprises the sum of three months' worth of ratings.

MMED Financial Forecast

MMED Earnings Forecast

Next quarter’s earnings estimate for MMED is $0.12 with a range of $0.07 to $0.22. The previous quarter’s EPS was -$0.68. MMED beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 45.32% of the time in the same period. In the last calendar year MMED has Performed in-line its overall industry.

MMED Sales Forecast

Next quarter’s sales forecast for MMED is $826.08M with a range of $810.28M to $833.00M. The previous quarter’s sales results were $837.00M. MMED beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 52.46% of the time in the same period. In the last calendar year MMED has Outperformed its overall industry.

MMED Stock Forecast FAQ

What is MMED’s average 12-month price target, according to analysts?

Based on analyst ratings, MiniMed Group, Inc.’s 12-month average price target is 21.60.

What is MMED’s upside potential, based on the analysts’ average price target?

MiniMed Group, Inc. has 10.20% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is MMED a Buy, Sell or Hold?

MiniMed Group, Inc. has a consensus rating of Strong Buy which is based on 11 buy ratings, 1 hold ratings and 0 sell ratings.

What is MiniMed Group, Inc.’s price target?

The average price target for MiniMed Group, Inc. is 21.60. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $26.00 ,the lowest forecast is $16.00. The average price target represents 10.20% Increase from the current price of $19.6.

What do analysts say about MiniMed Group, Inc.?

MiniMed Group, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of MMED?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

MiniMed Group, Inc. (MMED) Stock Forecast & Price Target

MMED Analyst Ratings

MMED Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering MiniMed Group, Inc.

MMED Analyst Recommendation Trends

MMED Financial Forecast

MMED Earnings Forecast

MMED Sales Forecast

MMED Stock Forecast FAQ

Detailed List of Analyst Forecasts